Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07737275

Screening With Portable X-rays for Rapid Recognition of TB

SPOT-TB (Screening with Portable X-rays for rapid recOgniTion of TB) is a prospective study evaluating a community-based tuberculosis (TB) screening strategy for migrant populations in New York City. The screening intervention integrates mobile ultra-portable digital chest radiography with artificial intelligence-assisted image interpretation, tuberculosis symptom assessment, latent tuberculosis infection testing, and HIV testing. Participants with concerning screening findings are referred for appropriate clinical evaluation. The study will evaluate the feasibility, acceptability, and effectiveness of this integrated screening strategy for improving early identification of active pulmonary tuberculosis and linkage to care in community settings.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

Tuberculosis (TB) remains a major public health challenge in the United States, with increasing numbers of reported cases in recent years. Delayed diagnosis contributes to ongoing transmission and poorer clinical outcomes, particularly among populations facing barriers to healthcare access. Migrant populations in New York City experience a disproportionately high burden of TB infection and disease, highlighting the need for innovative community-based screening strategies.

SPOT-TB (Screening with Portable X-rays for rapid recOgniTion of TB) is a prospective study evaluating a novel community-based TB screening strategy. The intervention combines mobile ultra-portable digital chest radiography, artificial intelligence-assisted image interpretation, tuberculosis symptom assessment, latent tuberculosis infection testing, and HIV testing to provide rapid, front-loaded screening while minimizing loss to follow-up. Participants with concerning screening findings are referred for appropriate clinical evaluation according to standard clinical practice.

The study will evaluate the feasibility, acceptability, and effectiveness of this integrated screening strategy for improving early identification of active pulmonary tuberculosis, facilitating linkage to care, and informing future community-based TB screening programs. The study will also provide information on TB and latent TB infection prevalence among migrant populations and the implementation of mobile AI-assisted screening in an urban U.S. setting.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult persons 18 years or older
  • Self-identifying as migrants to the US
  • Self-reporting migration within the 24 months

Exclusion criteria

  • Lack capacity for informed consent
  • Unable to perform translation/study materials not available in appropriate language
  • Unwilling to participate
  • Prisoner
  • Pregnancy

Treatment and study plan

Mobile chest radiography for tuberculosis screening

Diagnostic Test

The diagnostic screening includes a digital chest x-ray (includes AI software to interpret x-rays), optional lung ultrasound, oral swab for HIV testing, and a blood draw for TB testing.

Primary outcomes

  1. Completion of Appropriate Clinical Referrals

    Time frame: Up to 12 weeks post-visit

    Proportion of participants who complete recommended diagnostic evaluations and clinical referrals, stratified by tuberculosis risk screening group.

Study contacts

Contact information is provided by the study sponsor or research team.

Allison Wolf, MPH

CONTACT

[email protected]

212-342-44'1

Sponsors and collaborators

Lead sponsor

Columbia University

Other

Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

Registry information

Official study title

Mobilizing Innovative Strategies to Improve Tuberculosis (TB) Diagnosis and Retention in the TB Care Cascade for Migrant Communities in New York City

Acronym: SPOT-TB

Important dates

Study start
2026
Primary completion
2027
Study completion
2028
First posted
Jul 30, 2026
Registry last updated
Jul 30, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.